The most frequent adverse reaction during treatment with NeoRecormon is an increase in blood pressure or aggravation of existing hypertension, especially in cases of rapid PCV increase (see section 4.4).
Enamohustatud on patsiendid, kellel tekib ravi käigus kiire hematokriti tõus (vt lõik 4. 4).